Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trialKexiang Yan, Jinhua Xu, Rixin Chen et al.|Journal of the American Academy of Dermatology|2024Cited by 28
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical TrialYan Zhao, Jing Li, Bin Yang et al.|BioDrugs|2024Cited by 16
Guidelines for the diagnosis and treatment of prurigo nodularisLi Zhang, Xing‐Hua Gao, Qingchun Diao et al.|Chinese Medical Journal|2025Cited by 2